These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 30087232)

  • 1. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
    Yu J; Liu SL
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
    Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
    J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
    Wang Y; Pan Q; Ding S; Wang Z; Yu J; Finzi A; Liu SL; Liang C
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
    Wang B; Lam TH; Soh MK; Ye Z; Chen J; Ren EC
    Front Immunol; 2018; 9():1193. PubMed ID: 29904383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-Induced Transmembrane Proteins Inhibit Infection by the Kaposi's Sarcoma-Associated Herpesvirus and the Related Rhesus Monkey Rhadinovirus in a Cell-Specific Manner.
    Hörnich BF; Großkopf AK; Dcosta CJ; Schlagowski S; Hahn AS
    mBio; 2021 Dec; 12(6):e0211321. PubMed ID: 34933450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
    Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.
    Wu WL; Grotefend CR; Tsai MT; Wang YL; Radic V; Eoh H; Huang IC
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7112-7117. PubMed ID: 28630320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
    Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
    Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IFITM proteins inhibit HIV-1 infection.
    Lu J; Pan Q; Rong L; He W; Liu SL; Liang C
    J Virol; 2011 Mar; 85(5):2126-37. PubMed ID: 21177806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
    Blyth GA; Chan WF; Webster RG; Magor KE
    J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
    Foster TL; Wilson H; Iyer SS; Coss K; Doores K; Smith S; Kellam P; Finzi A; Borrow P; Hahn BH; Neil SJD
    Cell Host Microbe; 2016 Oct; 20(4):429-442. PubMed ID: 27640936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-receptors for HIV-1 entry.
    Moore JP; Trkola A; Dragic T
    Curr Opin Immunol; 1997 Aug; 9(4):551-62. PubMed ID: 9287172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
    Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
    J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alphavirus Restriction by IFITM Proteins.
    Weston S; Czieso S; White IJ; Smith SE; Wash RS; Diaz-Soria C; Kellam P; Marsh M
    Traffic; 2016 Sep; 17(9):997-1013. PubMed ID: 27219333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
    Yu J; Liang C; Liu SL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.
    Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS
    J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
    Joseph SB; Arrildt KT; Swanstrom AE; Schnell G; Lee B; Hoxie JA; Swanstrom R
    J Virol; 2014 Feb; 88(4):1858-69. PubMed ID: 24307580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1.
    Yi Y; Rana S; Turner JD; Gaddis N; Collman RG
    J Virol; 1998 Jan; 72(1):772-7. PubMed ID: 9420285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
    Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
    Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.